412 related articles for article (PubMed ID: 33753569)
1. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
Dettorre GM; Dolly S; Loizidou A; Chester J; Jackson A; Mukherjee U; Zambelli A; Aguilar-Company J; Bower M; Sng CCT; Salazar R; Bertuzzi A; Brunet J; Mesia R; Sita-Lumsden A; Seguí E; Biello F; Generali D; Grisanti S; Seeva P; Rizzo G; Libertini M; Maconi A; Moss C; Russell B; Harbeck N; Vincenzi B; Bertulli R; Ottaviani D; Liñan R; Marrari A; Carmona-García MC; Chopra N; Tondini CA; Mirallas O; Tovazzi V; Fotia V; Cruz CA; Saoudi-Gonzalez N; Felip E; Roqué A; Lee AJX; Newsom-Davis T; García-Illescas D; Reyes R; Wong YNS; Ferrante D; Scotti L; Marco-Hernández J; Ruiz-Camps I; Patriarca A; Rimassa L; Chiudinelli L; Franchi M; Santoro A; Prat A; Gennari A; Van Hemelrijck M; Tabernero J; Diamantis N; Pinato DJ;
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753569
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
[TBL] [Abstract][Full Text] [Related]
3. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE).
Castelo-Branco L; Tsourti Z; Gennatas S; Rogado J; Sekacheva M; Viñal D; Lee R; Croitoru A; Vitorino M; Khallaf S; Šušnjar S; Soewoto W; Cardeña A; Djerouni M; Rossi M; Alonso-Gordoa T; Ngelangel C; Whisenant JG; Choueiri TK; Dimopoulou G; Pradervand S; Arnold D; Harrington K; Michielin O; Dafni U; Pentheroudakis G; Peters S; Romano E
ESMO Open; 2022 Jun; 7(3):100499. PubMed ID: 35644101
[TBL] [Abstract][Full Text] [Related]
5. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
[TBL] [Abstract][Full Text] [Related]
6. The role of inflammatory indices in the outcome of COVID-19 cancer patients.
Nooh HA; Abdellateif MS; Refaat L; Kandeel EZ; Bayoumi A; Samra M; Khafagy M
Med Oncol; 2021 Nov; 39(1):6. PubMed ID: 34748094
[TBL] [Abstract][Full Text] [Related]
7. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
[TBL] [Abstract][Full Text] [Related]
9. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
10. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
[No Abstract] [Full Text] [Related]
11. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
Qi Q; Geng Y; Sun M; Wang P; Chen Z
Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
[TBL] [Abstract][Full Text] [Related]
12. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer.
Climent M; Ryan ÉJ; Stakelum Á; Khaw YL; Creavin B; Lloyd A; Alhassan D; Mohan HM; Kennelly R; Sheahan K; Winter DC
Int J Colorectal Dis; 2019 Jun; 34(6):1069-1078. PubMed ID: 30993458
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study.
Raffetti E; Donato F; Castelnuovo F; Ladisa N; Paraninfo G; Di Filippo E; Segala D; Cologni G; Bandera A; Zacchi F; Digiambenedetto S; Di Pietro M; Castelli F; Quiros-Roldan E;
J Transl Med; 2015 Mar; 13():89. PubMed ID: 25886534
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
16. Validation and clinical usefulness of pre- and postoperative systemic inflammatory parameters as prognostic markers in patients with potentially resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Ogata Y
Pancreatology; 2020 Mar; 20(2):239-246. PubMed ID: 31862230
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
19. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients.
Fois AG; Paliogiannis P; Scano V; Cau S; Babudieri S; Perra R; Ruzzittu G; Zinellu E; Pirina P; Carru C; Arru LB; Fancellu A; Mondoni M; Mangoni AA; Zinellu A
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291581
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
